Global Hypodermic Needles Market By Products (Safety Hypodermic Needles, Non-safety Hypodermic Needles), By Application (Drug Delivery, Vaccination, Blood Specimen Collection), By End Users (Hospital, Diabetic Patients, Family Practitioners, Psychiatry, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030

Hypodermic Needles Market

According to a new report published by , titled, “Global Hypodermic Needles Market:

A hypodermic needle is a hollow needle widely used across medical settings to carry out different applications, such as drug delivery, vaccination, and blood specimen collection. These needles function through two different mechanisms, namely safety and non-safety needles. They are used to administer and inject drugs in the body and also to withdraw fluids from the body for examination and research purposes.

Hypodermic needles also serve important roles in research requiring sterile conditions. The hypodermic needle significantly reduces contamination during inoculation of a sterile substrate in two ways. First, its surface is extremely smooth, preventing airborne pathogens from becoming trapped between irregularities on the needle’s surface, which could subsequently be transferred into the media as contaminants. Second, the needle’s point is extremely sharp, significantly reducing the diameter of the hole remaining after puncturing the membrane, which consequently prevents microbes larger than the hole from contaminating the substrate. Also because of  increase in applications of hypodermic needles, especially in clinics, hospitals, and by physicians has formulated the need of regulatory guidelines to evaluate the performance and quality of these needles. The International Organization for Standardization (ISO) has formed safety standards for their commercial use. These regulations provide guidance to determine the specification and minimum standards for hypodermic needles.

Needlestick injuries have a significant impact on the Hypodermic Needles Industry, and this impact is projected to further increase during the forecast period. This is attributed to the fact that needlestick injuries are the leading cause of blood-borne disease among healthcare professionals. The government and private organizations are taking certain initiatives to make advancement in the Hypodermic Needles Industry to prevent injuries occurred by needles, which is expected to propel the growth of the hypodermic needles market size. For instance, in June 2020, Beckton, Dickinson and Company (BD,) a leading global medical technology company, launched new ultratouch push button blood collection set with pre-attached holder that will help protect healthcare workers from the needlestick injury.

Also, B. Braun Medical Inc. launched its heparin sodium injection, the first Heparin 0.5 mL prefilled syringe with attached safety needle for subcutaneous and intravenous use in the U.S., in august 2019.

In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes, supplements the market growth. Increase in consumption of injectable drugs especially among diabetic patients and increase in preference of injectable drugs in comparison to oral drugs due to rapid onset & effective treatment drives the demand for hypodermic needles. In addition, rise in adoption of these needles for vaccination and immunization purposes is expected to boost the growth of the market.

Rise in incidence of chronic & lifestyle diseases, especially diabetes, , and increase in demand for advanced hypodermic needles solutions are expected to drive the Hypodermic Needles Market Growth. However, availability of alternative modes of drug delivery, low awareness towards safety syringes, and high cost of hypodermic needles hamper the market growth. The upsurge in demand for hypodermic needles, rise in disposable incomes, and growth prospects in emerging economies of Asia-Pacific and LAMEA are expected to provide numerous opportunities for market growth during the forecast period.

Depending on product type, the safety hypodermic needles segment dominated the market in 2020, and this trend is expected to continue during the forecast period, due to  increase in prevalence of the needlestick injury. The safety hypodermic needles are widely preferred over non-safety hypodermic needles, owing to the convenience and safety offered by these products along with advanced features, such as luer lock, single-handed technique, and other safety features.

Depending on application, the drug delivery segment dominated the market in 2020, and this trend is expected to continue during the forecast period. The injections, which employ hypodermic needles provide high drug absorption  and  less wastage of drugs, shorter onset time and accurate titration of the dosage. During vaccination, hypodermic needles are used to deliver the vaccines to the patients to treat various conditions such as influenza, hepatitis, pneumonia, and others. For blood specimen collection, sterile hypodermic needles are used to avoid the needlestick injuries to the blood donors, receivers, and healthcare providers and the risk associated with cross infection associated with blood transfusion.

Depending on end user Hypodermic Needles Market Analysis, hospitals are the largest end users of hypodermic needles in 2020, and this trend is expected to continue during the forecast period. Hospitals widely use hypodermic needles for various purposes, such as vaccination, drug delivery, blood specimen collection, and others. Also, hospitals of developed countries have made  it mandatory to use hypodermic needles. World Health Organization (WHO) has recommended all healthcare providers to switch over to safer needles to help prevent the spread of blood-borne diseases, such as hepatitis, HIV, and viral hemorrhagic fevers. There is increase in activities in the healthcare sector owing to high demand for hypodermic needles in hospitals and health maintenance organization HMOs globally. In addition, hospitals and health maintenance organization (HMO's) consistently collaborate with safety needle manufacturers, distributors, and organizations for medical supplies of hypodermic needles across all hospitals and HMOs.

Asia-Pacific garnered a major in the hypodermic needles market share in 2020, and is expected to continue to dominate during the forecast period, owing to increase in prevalence of chronic diseases, presence of a high population base (with India and China being the most populated countries), presence of unmet medical needs, and increase in disposable incomes of people in this region. However, based on Hypodermic Needles Market Forecast, Europe is expected to register second highest share in 2020, owing to increase in prevalence diabetes, presence of key players in region, and well developed healthcare infrastructure in this region.

Overview

The global hypodermic needles market size was valued at $3,256.00 million in 2020, and is expected to garner $4,537.99 million by 2030, registering a CAGR of 3.4 % during the forecast period 2021–2030.

A hypodermic needle is a hollow needle widely used across medical settings to carry out different applications, such as drug delivery, vaccination, and blood specimen collection. These needles function through two different mechanisms, namely safety and non-safety needles. They are used to administer and inject drugs in the body and also to withdraw fluids from the body for examination and research purposes.

The growth of the global hypodermic needles market size is driven by increase in incidences of needlestick injuries. According to World Health Organization, it was estimated that 296 million people were living with chronic hepatitis B infection in 2019, with 1.5 million new infections each year in 2019. Hepatitis B resulted in an estimated 820, 000 deaths, and hundreds of thousands of healthcare workers were at high risk of work-related infections, such as hepatitis B, hepatitis C, and HIV due to exposure to contaminated needle sticks and sharp injuries. In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes, supplements the hypodermic needles market growth. However, availability of alternative modes of drug delivery, low awareness towards safety syringes, and high cost of hypodermic needles hamper the hypodermic needles industry. Based on hypodermic needles market analysis, the untapped emerging economies present lucrative opportunities for the market.

The hypodermic needles market is segmented on the basis of product type, application, end user, and region. On the basis of product type, the market is bifurcated into safety and non-safety hypodermic needles. The safety hypodermic needles segment is sub-segmented on the basis of type and mode of activation.

By type, safety hypodermic needles are divided into retractable and nonretractable needles. By mode of activation, they are classified into active and passive hypodermic needles.

The safety hypodermic needle segment holds the largest market share owing to the technological advancements, prevention of needlestick injuries, and safety mechanisms embedded in these needles.

By applications, the market if divided into drug delivery, vaccination, and blood specimen collection. The drug delivery application was the highest revenue contributor in 2020. However, the vaccination segment is anticipated to grow at the highest rate during the forecast period owing to high birth rates and increase in awareness towards vaccination globally.

By end user, the hypodermic needles market includes hospitals, diabetic patient, family practitioner, psychiatry and others. World Health Organization (WHO) has recommended all healthcare providers to switch over to safer needles and helps prevent the spread of blood-borne diseases such as hepatitis, HIV, and viral hemorrhagic fevers. Hospitals are the largest end users of hypodermic needles. Hospitals that are publicly or privately owned, multinational hospitals, specialty hospitals, and others, widely use hypodermic needles for various purposes such as vaccination, drug delivery, blood specimen collection, and others.

Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific accounted for the largest hypodermic needles market share in 2020, and is expected to maintain its dominance during the forecast period. This is attributed to higher buying power and stringent regulations that favor the utilization of hypodermic needles. In addition, increase in awareness towards the risk of cross infection (such as hepatitis, HIV, and AIDS) and needlestick injuries, boosts the adoption of safety hypodermic needles. Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to improvements in healthcare facilities, increase in disposable income, and rapid development of economic conditions.

The key players that operate in the global hypodermic needles market include, Becton, Dickinson and Company, B. Braun Melsungen Ag, Cardinal Health Inc., Connecticut Hypodermics Inc., Exelint International Co., Mckesson Corporation, Hi-tech syringes, Retractable Technologies, Inc., Nipro Corporation, and Terumo Medical Corporation.

 

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global hypodermic needles market analysis from 2020 to 2030 to identify the prevailing global hypodermic needles market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the global hypodermic needles market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global global hypodermic needles market trends, key players, market segments, application areas, and market growth strategies.

 

Key Market Segments

TERUMO MEDICAL CORPORATIO

Scope of Hypodermic Needles Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Safety Hypodermic Needles

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Non-safety Hypodermic Needles

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Drug Delivery

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Vaccination

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Blood Specimen Collection

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Hospital

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 Diabetic Patients

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

6.4 Family Practitioners

6.4.1 Key market trends, growth factors and opportunities

6.4.2 Market size and forecast, by region

6.4.3 Market analysis by country

6.5 Psychiatry

6.5.1 Key market trends, growth factors and opportunities

6.5.2 Market size and forecast, by region

6.5.3 Market analysis by country

6.6 Others

6.6.1 Key market trends, growth factors and opportunities

6.6.2 Market size and forecast, by region

6.6.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key trends and opportunities

7.2.2 North America Market size and forecast, by Products

7.2.3 North America Market size and forecast, by Application

7.2.4 North America Market size and forecast, by End Users

7.2.5 North America Market size and forecast, by country

7.2.5.1 U.S.

7.2.5.1.1 Market size and forecast, by Products

7.2.5.1.2 Market size and forecast, by Application

7.2.5.1.3 Market size and forecast, by End Users

7.2.5.2 Canada

7.2.5.2.1 Market size and forecast, by Products

7.2.5.2.2 Market size and forecast, by Application

7.2.5.2.3 Market size and forecast, by End Users

7.2.5.3 Mexico

7.2.5.3.1 Market size and forecast, by Products

7.2.5.3.2 Market size and forecast, by Application

7.2.5.3.3 Market size and forecast, by End Users

7.3 Europe

7.3.1 Key trends and opportunities

7.3.2 Europe Market size and forecast, by Products

7.3.3 Europe Market size and forecast, by Application

7.3.4 Europe Market size and forecast, by End Users

7.3.5 Europe Market size and forecast, by country

7.3.5.1 Germany

7.3.5.1.1 Market size and forecast, by Products

7.3.5.1.2 Market size and forecast, by Application

7.3.5.1.3 Market size and forecast, by End Users

7.3.5.2 France

7.3.5.2.1 Market size and forecast, by Products

7.3.5.2.2 Market size and forecast, by Application

7.3.5.2.3 Market size and forecast, by End Users

7.3.5.3 U.K.

7.3.5.3.1 Market size and forecast, by Products

7.3.5.3.2 Market size and forecast, by Application

7.3.5.3.3 Market size and forecast, by End Users

7.3.5.4 Italy

7.3.5.4.1 Market size and forecast, by Products

7.3.5.4.2 Market size and forecast, by Application

7.3.5.4.3 Market size and forecast, by End Users

7.3.5.5 Spain

7.3.5.5.1 Market size and forecast, by Products

7.3.5.5.2 Market size and forecast, by Application

7.3.5.5.3 Market size and forecast, by End Users

7.3.5.6 "Rest Of Europe "

7.3.5.6.1 Market size and forecast, by Products

7.3.5.6.2 Market size and forecast, by Application

7.3.5.6.3 Market size and forecast, by End Users

7.4 Asia-Pacific

7.4.1 Key trends and opportunities

7.4.2 Asia-Pacific Market size and forecast, by Products

7.4.3 Asia-Pacific Market size and forecast, by Application

7.4.4 Asia-Pacific Market size and forecast, by End Users

7.4.5 Asia-Pacific Market size and forecast, by country

7.4.5.1 Japan

7.4.5.1.1 Market size and forecast, by Products

7.4.5.1.2 Market size and forecast, by Application

7.4.5.1.3 Market size and forecast, by End Users

7.4.5.2 China

7.4.5.2.1 Market size and forecast, by Products

7.4.5.2.2 Market size and forecast, by Application

7.4.5.2.3 Market size and forecast, by End Users

7.4.5.3 Australia

7.4.5.3.1 Market size and forecast, by Products

7.4.5.3.2 Market size and forecast, by Application

7.4.5.3.3 Market size and forecast, by End Users

7.4.5.4 India

7.4.5.4.1 Market size and forecast, by Products

7.4.5.4.2 Market size and forecast, by Application

7.4.5.4.3 Market size and forecast, by End Users

7.4.5.5 South Korea

7.4.5.5.1 Market size and forecast, by Products

7.4.5.5.2 Market size and forecast, by Application

7.4.5.5.3 Market size and forecast, by End Users

7.4.5.6 Taiwan, Republic Of China

7.4.5.6.1 Market size and forecast, by Products

7.4.5.6.2 Market size and forecast, by Application

7.4.5.6.3 Market size and forecast, by End Users

7.4.5.7 Rest of Asia-Pacific

7.4.5.7.1 Market size and forecast, by Products

7.4.5.7.2 Market size and forecast, by Application

7.4.5.7.3 Market size and forecast, by End Users

7.5 LAMEA

7.5.1 Key trends and opportunities

7.5.2 LAMEA Market size and forecast, by Products

7.5.3 LAMEA Market size and forecast, by Application

7.5.4 LAMEA Market size and forecast, by End Users

7.5.5 LAMEA Market size and forecast, by country

7.5.5.1 Brazil

7.5.5.1.1 Market size and forecast, by Products

7.5.5.1.2 Market size and forecast, by Application

7.5.5.1.3 Market size and forecast, by End Users

7.5.5.2 Saudi Arabia

7.5.5.2.1 Market size and forecast, by Products

7.5.5.2.2 Market size and forecast, by Application

7.5.5.2.3 Market size and forecast, by End Users

7.5.5.3 South Africa

7.5.5.3.1 Market size and forecast, by Products

7.5.5.3.2 Market size and forecast, by Application

7.5.5.3.3 Market size and forecast, by End Users

7.5.5.4 Rest of LAMEA

7.5.5.4.1 Market size and forecast, by Products

7.5.5.4.2 Market size and forecast, by Application

7.5.5.4.3 Market size and forecast, by End Users

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Key developments

9.1 Becton, Dickinson and Company

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Operating business segments

9.1.4 Product portfolio

9.1.5 Business performance

9.1.6 Key strategic moves and developments

9.2 B. BRAUN MELSUNGEN AG

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Operating business segments

9.2.4 Product portfolio

9.2.5 Business performance

9.2.6 Key strategic moves and developments

9.3 Cardinal Health Inc.

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Operating business segments

9.3.4 Product portfolio

9.3.5 Business performance

9.3.6 Key strategic moves and developments

9.4 CONNECTICUT HYPODERMICS INC.

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Operating business segments

9.4.4 Product portfolio

9.4.5 Business performance

9.4.6 Key strategic moves and developments

9.5 EXELINT INTERNATIONAL CO.

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Operating business segments

9.5.4 Product portfolio

9.5.5 Business performance

9.5.6 Key strategic moves and developments

9.6 McKesson Corporation

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Operating business segments

9.6.4 Product portfolio

9.6.5 Business performance

9.6.6 Key strategic moves and developments

9.7 Hitech Syringes

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Operating business segments

9.7.4 Product portfolio

9.7.5 Business performance

9.7.6 Key strategic moves and developments

9.8 Retractable Technologies, Inc.

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Operating business segments

9.8.4 Product portfolio

9.8.5 Business performance

9.8.6 Key strategic moves and developments

9.9 Nipro Corporation

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Operating business segments

9.9.4 Product portfolio

9.9.5 Business performance

9.9.6 Key strategic moves and developments

9.10 TERUMO MEDICAL CORPORATION

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Operating business segments

9.10.4 Product portfolio

9.10.5 Business performance

9.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL GLOBAL HYPODERMIC NEEDLES MARKET, BY PRODUCTS, 2020-2030,($MILLION)

TABLE 2. GLOBAL HYPODERMIC NEEDLES MARKET REVENUE, FOR SAFETY HYPODERMIC NEEDLES, BY REGION , 2020-2030,($MILLION)

TABLE 3. GLOBAL HYPODERMIC NEEDLES MARKET SAFETY HYPODERMIC NEEDLES BY COUNTRY, 2020-2030,($MILLION)

TABLE 4. GLOBAL HYPODERMIC NEEDLES MARKET REVENUE, FOR NON-SAFETY HYPODERMIC NEEDLES, BY REGION , 2020-2030,($MILLION)

TABLE 5. GLOBAL HYPODERMIC NEEDLES MARKET NON-SAFETY HYPODERMIC NEEDLES BY COUNTRY, 2020-2030,($MILLION)

TABLE 6. GLOBAL GLOBAL HYPODERMIC NEEDLES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 7. GLOBAL HYPODERMIC NEEDLES MARKET REVENUE, FOR DRUG DELIVERY, BY REGION , 2020-2030,($MILLION)

TABLE 8. GLOBAL HYPODERMIC NEEDLES MARKET DRUG DELIVERY BY COUNTRY, 2020-2030,($MILLION)

TABLE 9. GLOBAL HYPODERMIC NEEDLES MARKET REVENUE, FOR VACCINATION, BY REGION , 2020-2030,($MILLION)

TABLE 10. GLOBAL HYPODERMIC NEEDLES MARKET VACCINATION BY COUNTRY, 2020-2030,($MILLION)

TABLE 11. GLOBAL HYPODERMIC NEEDLES MARKET REVENUE, FOR BLOOD SPECIMEN COLLECTION, BY REGION , 2020-2030,($MILLION)

TABLE 12. GLOBAL HYPODERMIC NEEDLES MARKET BLOOD SPECIMEN COLLECTION BY COUNTRY, 2020-2030,($MILLION)

TABLE 13. GLOBAL GLOBAL HYPODERMIC NEEDLES MARKET, BY END USERS, 2020-2030,($MILLION)

TABLE 14. GLOBAL HYPODERMIC NEEDLES MARKET REVENUE, FOR HOSPITAL, BY REGION , 2020-2030,($MILLION)

TABLE 15. GLOBAL HYPODERMIC NEEDLES MARKET HOSPITAL BY COUNTRY, 2020-2030,($MILLION)

TABLE 16. GLOBAL HYPODERMIC NEEDLES MARKET REVENUE, FOR DIABETIC PATIENTS, BY REGION , 2020-2030,($MILLION)

TABLE 17. GLOBAL HYPODERMIC NEEDLES MARKET DIABETIC PATIENTS BY COUNTRY, 2020-2030,($MILLION)

TABLE 18. GLOBAL HYPODERMIC NEEDLES MARKET REVENUE, FOR FAMILY PRACTITIONERS, BY REGION , 2020-2030,($MILLION)

TABLE 19. GLOBAL HYPODERMIC NEEDLES MARKET FAMILY PRACTITIONERS BY COUNTRY, 2020-2030,($MILLION)

TABLE 20. GLOBAL HYPODERMIC NEEDLES MARKET REVENUE, FOR PSYCHIATRY, BY REGION , 2020-2030,($MILLION)

TABLE 21. GLOBAL HYPODERMIC NEEDLES MARKET PSYCHIATRY BY COUNTRY, 2020-2030,($MILLION)

TABLE 22. GLOBAL HYPODERMIC NEEDLES MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)

TABLE 23. GLOBAL HYPODERMIC NEEDLES MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)

TABLE 24. GLOBAL HYPODERMIC NEEDLES MARKET, BY REGION, 2020-2030,($MILLION)

TABLE 25. NORTH AMERICA GLOBAL HYPODERMIC NEEDLES MARKET, BY PRODUCTS, 2020-2030,($MILLION)

TABLE 26. NORTH AMERICA GLOBAL HYPODERMIC NEEDLES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 27. NORTH AMERICA GLOBAL HYPODERMIC NEEDLES MARKET, BY END USERS, 2020-2030,($MILLION)

TABLE 28. NORTH AMERICA GLOBAL HYPODERMIC NEEDLES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 29. U.S. GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 30. U.S. GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 31. U.S. GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 32. CANADA GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 33. CANADA GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 34. CANADA GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 35. MEXICO GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 36. MEXICO GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 37. MEXICO GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 38. EUROPE GLOBAL HYPODERMIC NEEDLES MARKET, BY PRODUCTS, 2020-2030,($MILLION)

TABLE 39. EUROPE GLOBAL HYPODERMIC NEEDLES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 40. EUROPE GLOBAL HYPODERMIC NEEDLES MARKET, BY END USERS, 2020-2030,($MILLION)

TABLE 41. EUROPE GLOBAL HYPODERMIC NEEDLES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 42. GERMANY GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 43. GERMANY GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 44. GERMANY GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 45. FRANCE GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 46. FRANCE GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 47. FRANCE GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 48. U.K. GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 49. U.K. GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 50. U.K. GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 51. ITALY GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 52. ITALY GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 53. ITALY GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 54. SPAIN GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 55. SPAIN GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 56. SPAIN GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 57. "REST OF EUROPE " GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 58. "REST OF EUROPE " GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 59. "REST OF EUROPE " GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 60. ASIA-PACIFIC GLOBAL HYPODERMIC NEEDLES MARKET, BY PRODUCTS, 2020-2030,($MILLION)

TABLE 61. ASIA-PACIFIC GLOBAL HYPODERMIC NEEDLES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 62. ASIA-PACIFIC GLOBAL HYPODERMIC NEEDLES MARKET, BY END USERS, 2020-2030,($MILLION)

TABLE 63. ASIA-PACIFIC GLOBAL HYPODERMIC NEEDLES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 64. JAPAN GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 65. JAPAN GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 66. JAPAN GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 67. CHINA GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 68. CHINA GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 69. CHINA GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 70. AUSTRALIA GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 71. AUSTRALIA GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 72. AUSTRALIA GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 73. INDIA GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 74. INDIA GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 75. INDIA GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 76. SOUTH KOREA GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 77. SOUTH KOREA GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 78. SOUTH KOREA GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 79. TAIWAN, REPUBLIC OF CHINA GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 80. TAIWAN, REPUBLIC OF CHINA GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 81. TAIWAN, REPUBLIC OF CHINA GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 82. REST OF ASIA-PACIFIC GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 83. REST OF ASIA-PACIFIC GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 84. REST OF ASIA-PACIFIC GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 85. LAMEA GLOBAL HYPODERMIC NEEDLES MARKET, BY PRODUCTS, 2020-2030,($MILLION)

TABLE 86. LAMEA GLOBAL HYPODERMIC NEEDLES MARKET, BY APPLICATION, 2020-2030,($MILLION)

TABLE 87. LAMEA GLOBAL HYPODERMIC NEEDLES MARKET, BY END USERS, 2020-2030,($MILLION)

TABLE 88. LAMEA GLOBAL HYPODERMIC NEEDLES MARKET, BY COUNTRY, 2020-2030,($MILLION)

TABLE 89. BRAZIL GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 90. BRAZIL GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 91. BRAZIL GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 92. SAUDI ARABIA GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 93. SAUDI ARABIA GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 94. SAUDI ARABIA GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 95. SOUTH AFRICA GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 96. SOUTH AFRICA GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 97. SOUTH AFRICA GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 98. REST OF LAMEA GLOBAL HYPODERMIC NEEDLES MARKET BY PRODUCTS 2020-2030,($MILLION)

TABLE 99. REST OF LAMEA GLOBAL HYPODERMIC NEEDLES MARKET BY APPLICATION 2020-2030,($MILLION)

TABLE 100. REST OF LAMEA GLOBAL HYPODERMIC NEEDLES MARKET BY END USERS 2020-2030,($MILLION)

TABLE 101.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT

TABLE 102.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS

TABLE 103.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO

TABLE 104.BECTON, DICKINSON AND COMPANY: NET SALES,

TABLE 105.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES

TABLE 106.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT

TABLE 107.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS

TABLE 108.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO

TABLE 109.B. BRAUN MELSUNGEN AG: NET SALES,

TABLE 110.B. BRAUN MELSUNGEN AG: KEY STRATERGIES

TABLE 111.CARDINAL HEALTH INC.: COMPANY SNAPSHOT

TABLE 112.CARDINAL HEALTH INC.: OPERATING SEGMENTS

TABLE 113.CARDINAL HEALTH INC.: PRODUCT PORTFOLIO

TABLE 114.CARDINAL HEALTH INC.: NET SALES,

TABLE 115.CARDINAL HEALTH INC.: KEY STRATERGIES

TABLE 116.CONNECTICUT HYPODERMICS INC.: COMPANY SNAPSHOT

TABLE 117.CONNECTICUT HYPODERMICS INC.: OPERATING SEGMENTS

TABLE 118.CONNECTICUT HYPODERMICS INC.: PRODUCT PORTFOLIO

TABLE 119.CONNECTICUT HYPODERMICS INC.: NET SALES,

TABLE 120.CONNECTICUT HYPODERMICS INC.: KEY STRATERGIES

TABLE 121.EXELINT INTERNATIONAL CO.: COMPANY SNAPSHOT

TABLE 122.EXELINT INTERNATIONAL CO.: OPERATING SEGMENTS

TABLE 123.EXELINT INTERNATIONAL CO.: PRODUCT PORTFOLIO

TABLE 124.EXELINT INTERNATIONAL CO.: NET SALES,

TABLE 125.EXELINT INTERNATIONAL CO.: KEY STRATERGIES

TABLE 126.MCKESSON CORPORATION: COMPANY SNAPSHOT

TABLE 127.MCKESSON CORPORATION: OPERATING SEGMENTS

TABLE 128.MCKESSON CORPORATION: PRODUCT PORTFOLIO

TABLE 129.MCKESSON CORPORATION: NET SALES,

TABLE 130.MCKESSON CORPORATION: KEY STRATERGIES

TABLE 131.HITECH SYRINGES: COMPANY SNAPSHOT

TABLE 132.HITECH SYRINGES: OPERATING SEGMENTS

TABLE 133.HITECH SYRINGES: PRODUCT PORTFOLIO

TABLE 134.HITECH SYRINGES: NET SALES,

TABLE 135.HITECH SYRINGES: KEY STRATERGIES

TABLE 136.RETRACTABLE TECHNOLOGIES, INC.: COMPANY SNAPSHOT

TABLE 137.RETRACTABLE TECHNOLOGIES, INC.: OPERATING SEGMENTS

TABLE 138.RETRACTABLE TECHNOLOGIES, INC.: PRODUCT PORTFOLIO

TABLE 139.RETRACTABLE TECHNOLOGIES, INC.: NET SALES,

TABLE 140.RETRACTABLE TECHNOLOGIES, INC.: KEY STRATERGIES

TABLE 141.NIPRO CORPORATION: COMPANY SNAPSHOT

TABLE 142.NIPRO CORPORATION: OPERATING SEGMENTS

TABLE 143.NIPRO CORPORATION: PRODUCT PORTFOLIO

TABLE 144.NIPRO CORPORATION: NET SALES,

TABLE 145.NIPRO CORPORATION: KEY STRATERGIES

TABLE 146.TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT

TABLE 147.TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS

TABLE 148.TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO

TABLE 149.TERUMO MEDICAL CORPORATION: NET SALES,

TABLE 150.TERUMO MEDICAL CORPORATION: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.GLOBAL HYPODERMIC NEEDLES MARKET SEGMENTATION

FIGURE 2.GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030

FIGURE 3.GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.GLOBAL HYPODERMIC NEEDLES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.GLOBAL HYPODERMIC NEEDLES MARKET,BY PRODUCTS,2020(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SAFETY HYPODERMIC NEEDLES GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF NON-SAFETY HYPODERMIC NEEDLES GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030(%)

FIGURE 15.GLOBAL HYPODERMIC NEEDLES MARKET,BY APPLICATION,2020(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DRUG DELIVERY GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF VACCINATION GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF BLOOD SPECIMEN COLLECTION GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030(%)

FIGURE 19.GLOBAL HYPODERMIC NEEDLES MARKET,BY END USERS,2020(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HOSPITAL GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030(%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DIABETIC PATIENTS GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030(%)

FIGURE 22.COMPARATIVE SHARE ANALYSIS OF FAMILY PRACTITIONERS GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF PSYCHIATRY GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030(%)

FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030(%)

FIGURE 25.GLOBAL HYPODERMIC NEEDLES MARKET BY REGION,2020

FIGURE 26.U.S. GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 27.CANADA GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 28.MEXICO GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 29.GERMANY GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 30.FRANCE GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 31.U.K. GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 32.ITALY GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 33.SPAIN GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 34."REST OF EUROPE " GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 35.JAPAN GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 36.CHINA GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 37.AUSTRALIA GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 38.INDIA GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 39.SOUTH KOREA GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 40.TAIWAN, REPUBLIC OF CHINA GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 41.REST OF ASIA-PACIFIC GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 42.BRAZIL GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 43.SAUDI ARABIA GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 44.SOUTH AFRICA GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 45.REST OF LAMEA GLOBAL HYPODERMIC NEEDLES MARKET,2020-2030($MILLION)

FIGURE 46. TOP WINNING STRATEGIES, BY YEAR

FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 49.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 50.COMPETITIVE DASHBOARD

FIGURE 51.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 52.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)

FIGURE 53.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)

FIGURE 54.CARDINAL HEALTH INC..: NET SALES ,($MILLION)

FIGURE 55.CONNECTICUT HYPODERMICS INC..: NET SALES ,($MILLION)

FIGURE 56.EXELINT INTERNATIONAL CO..: NET SALES ,($MILLION)

FIGURE 57.MCKESSON CORPORATION.: NET SALES ,($MILLION)

FIGURE 58.HITECH SYRINGES.: NET SALES ,($MILLION)

FIGURE 59.RETRACTABLE TECHNOLOGIES, INC..: NET SALES ,($MILLION)

FIGURE 60.NIPRO CORPORATION.: NET SALES ,($MILLION)

FIGURE 61.TERUMO MEDICAL CORPORATION.: NET SALES ,($MILLION